Gastroenterology
Volume 128, Issue 4, Supplement 1 , Pages S33-S37, April 2005

Genetic testing: Who should do the testing and what is the role of genetic testing in the setting of celiac disease?

Presented at the NIH Consensus Development Conference on Celiac Disease, June 28–30, 2004.

  • Edwin Liu
  • ,
  • Marian Rewers
  • ,
  • George S. Eisenbarth

      Affiliations

    • Corresponding Author InformationAddress requests for reprints to: George S. Eisenbarth, MD, Barbara Davis Center for Childhood Diabetes, University of Colorado Health Sciences Center, 4200 East 9th Avenue, B290, Denver, Colorado 80262. fax: (303) 315-4892.

Barbara Davis Center for Childhood Diabetes, University of Colorado Health Sciences Center, Denver, Colorado

Celiac disease is a remarkable and common immune-mediated disorder determined by both the presence of characteristic HLA alleles (DQ2 and DQ8) and one of the best characterized environmental factors (gliadin) for any common autoimmune disease. The discovery of transglutaminase autoantibodies and the development of assays for these antibodies has allowed the identification of a large number of asymptomatic individuals with autoimmunity and intestinal biopsy evidence of celiac lesions. Further understanding of the sequelae of asymptomatic celiac disease, and the interaction between genetic susceptibility and environmental factors, are likely to alter fundamentally both genetic screening for celiac disease and its therapy.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 30.00 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 Supported by National Institute of Health grants DK 32083, A146374, DK57516; the Diabetes Endocrine Research Center (P30 DK57516); the National Institutes of Health Clinical Research Centers Program (MO1 RR00069, MO1 RR00051); and by K08064605-02 (E.L.).

PII: S0016-5085(05)00182-4

doi:10.1053/j.gastro.2005.02.013

Gastroenterology
Volume 128, Issue 4, Supplement 1 , Pages S33-S37, April 2005